To investigate the current prevalence and longitudinal evolution of anti-JCV antibody index in MS patients screened to start DMTs
Latest Information Update: 10 Jan 2020
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis; Polyomavirus infections
- Focus Pharmacodynamics
Most Recent Events
- 10 Jan 2020 New trial record